ClearPoint Neuro Inc. (CLPT)
NASDAQ: CLPTHealthcareMedical DevicesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
CLPT stock chart
Technical analysisKey statistics
All statistics- Market cap
- $325.18M
- EPS (TTM)
- -$1.14
- Dividend yield
- None
- 52-week range
- 8.27 – 30.10
- Day range
- 10.58 – 10.98
- Volume / Avg
- 490.13K / 639.50K
- Beta
- —
- Shares outstanding
- 30.50M
- Next earnings
- Nov 5, 2026
52-week range
CLPT stock today
ClearPoint Neuro (CLPT) closed at $10.66 on Oct 7, down 3.18% (-$0.35), versus the S&P 500's 0.22% decline. Shares are 64.6% below their 52-week high of $30.10, set on Oct 9, 2025 and 28.9% above the 52-week low of $8.27, near the bottom of the past year's range. CLPT is down 22.1% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 59.6%.
ClearPoint Neuro has posted a net loss over the last twelve months (EPS of -$1.14), so its P/E ratio is not meaningful. ClearPoint Neuro's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About ClearPoint Neuro
Company profileClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula. It also provides ClearPoint software, which guides the physician in surgical planning, device alignment, navigation to the target, and procedure monitoring; ClearPoint Prism Neuro laser therapy system to necrotize or coagulate soft tissue; and IRRAflow system, an active fluid exchange platform.
- Sector
- Healthcare
- Industry
- Medical Devices
- CEO
- Mr. Joseph Michael Burnett
- Headquarters
- Solana Beach, CA
- Employees
- 160
- Website
- clearpointneuro.com
Analyst forecast
ForecastConsensus (2 analysts)
strong_buy
Avg. price target
$23.50+120.45%
- Strong buy 0
- Buy 2
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.27
ClearPoint Neuro peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CVCapsoVision Inc. | 6.54 | +0.62% | $348.00M | vs CLPT |
| VMDViemed Healthcare Inc. | 9.37 | +0.43% | $356.89M | vs CLPT |
| MOBIMobia Medical Inc. | 8.51 | -3.30% | $283.31M | vs CLPT |
| CATXPerspective Therapeutics Inc. | 2.46 | +4.24% | $280.81M | vs CLPT |
| QSIQuantum-Si Incorporated Class A | 1.28 | +4.92% | $280.17M | vs CLPT |
| OFIXOrthofix Medical Inc. | 9.20 | -2.23% | $371.88M | vs CLPT |
| LABStandard BioTools Inc. | 0.6787 | -6.00% | $266.44M | vs CLPT |
| INFUInfuSystems Holdings Inc. | 13.33 | +0.45% | $265.50M | vs CLPT |
Indexes, lists and sector
Appears in lists
ClearPoint Neuro stock FAQ
What is ClearPoint Neuro's stock price today?
CLPT last traded at $10.66 as of Oct 7, 4:00 PM EDT, down 3.18% on the day. Prices are delayed at least 15 minutes.
Does ClearPoint Neuro pay a dividend?
No. ClearPoint Neuro does not currently pay a regular cash dividend.
When is ClearPoint Neuro's next earnings date?
ClearPoint Neuro is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.27.
Who is ClearPoint Neuro's CEO?
Mr. Joseph Michael Burnett is the chief executive officer of ClearPoint Neuro Inc., which has about 160 employees.
Has CLPT ever split its stock?
Yes. The most recent CLPT stock split was a 1-for-40 split on Jul 27, 2016.
What is the CLPT 52-week high?
The 52-week high for CLPT is $30.10 and the 52-week low is $8.27. The stock is currently 64.6% below its high.